alogliptin 12.5 MG / metformin hydrochloride 1000 MG Oral Tablet [Kazano]
RxNorm concept 1368391, branded drug (sbd). Prescribable name: Kazano 12.5 MG / 1000 MG Oral Tablet.
- RxCUI
- 1368391
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1368391 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Kazano 12.5/1000 (as alogliptin benzoate 17 MG / metFORMIN hydrochloride) Oral Tablet; Kazano 12.5/1000 (as alogliptin benzoate 17 MG / metformin hydrochloride) Oral Tablet; Kazano 12.5/1000 Oral Tablet; alogliptin 12.5 MG / metFORMIN hydrochloride 1000 MG Oral Tablet [Kazano]
Related concepts
- metformin hydrochloride 1000 MG (SCDC, consists of)
- alogliptin 12.5 MG (SCDC, consists of)
- alogliptin 12.5 MG / metformin hydrochloride 1000 MG [Kazano] (SBDC, consists of)
- Oral Tablet (DF, has dose form)
- Kazano (BN, has ingredient)
- alogliptin 12.5 MG / metformin hydrochloride 1000 MG Oral Tablet (SCD, tradename of)
Linked data
NDCs
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 1368391 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1368391 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1368391. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.